Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 619-622

  Hahn, Heidi ^a   Wojnowski, Leszek ^a   Zimmer, Anne M ^a   Hall, Jennifer ^a   Miller, Georgina ^b   Zimmer, Andreas ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SOMATOMEDIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL NEVUS SYNDROME; CONTROLLED STUDY; EMBRYO; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOTE; IONIZING RADIATION; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIOSENSITIVITY; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION;

ANIMALS; BASAL CELL NEVUS SYNDROME; CESIUM RADIOISOTOPES; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMBRYO; HETEROZYGOTE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS; RADIATION TOLERANCE; RECEPTORS, CELL SURFACE; RHABDOMYOSARCOMA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0031837454     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-619     Document Type: Article

References (20)

1. Bal, A.E. Variable expressivity of patched mutations in flies and humans. Am. J. Hum. Genet. 60, 10-2 (1997).
2. Gorlin, R.J. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66, 98-113 (1987).
3. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-51 (1996).
4. Johnson, R.L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-71 (1996).
5. Pappo, A.S., Shapiro, D.N. & Crist, W.M. Rhabdomyosarcoma. Biology and treatment. Pediatr. Clin. North. Am. 44, 953-72 (1997).
6. Goodrich, L.V., Milenkovic, L., Higgins, K.M. & Scott, M.P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-13 (1997).
7. Dahmane, N. et al. Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-81 (1997).
8. Zhan, S. et al. Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer. J. Biol. Chem. 270, 27983-6 (1995).
9. Hall, E.J. Effects of radiation on the embryo and fetus. In: Radiology for the radiologist (J.B. Lippincott Company,-Philadelphia, 1994).
10. Cossu, G., Tajbakhsh, S. & Buckingham, M. How is myogenesis initiated in the embryo? Trends Genet. 12, 218-23 (1996).
11. Hynes, M. et al. Control of cell pattern in the neural tube by the zinc finger transcription factor and oncogene Gli-1. Neuron 19, 15-26 (1997).
12. Albrecht, S. et al. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma. J. Neuropathol. Exp. Neurol. 55, 1270-6 (1996).
13. Sun, F.L., Dean, W.L., Kelsey, G., Allen, N.D. & Reik, W. Transition of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. Nature 389, 809-15 (1997).
14. Shapiro, D.N., Sublett, J.E., Li, B., Downing, J.R. & Naeve, C.W. Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53, 5108-12 (1993).
15. Rugh, R. The mouse: its reproduction and development (Oxford University Press, New-York, 1990).
16. Goodrich, L.V., Johnson, R.L., Milenkovic, L., McMahon, J.A. & Scott, M.P. Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev. 10, 301-12 (1996).
17. Levanat, S. et al. A two-hit model for developmental defects in Gorlin syndrome. Nature Genet. 12, 85-87 (1996).
18. Arlett, C.F. & Priestley, A. Deficient recovery from potentially lethal damage in some gamma-irradiated human fibroblast cell strains. Br. J. Cancer Suppl. 6, 227-32 (1984).
19. Featherstone, T., Taylor, A.M. & Harnden, D.G. Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am. J. Hum. Genet. 35, 58-66 (1983).
20. Waldman, T. et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med. 3, 1034-6 (1997).